4
Changes in Ownership
Vistagen Therapeutics, Inc. Filed Acc 0001998663-26-000006
Options or other derivatives
- Chief Operating Officer acquired 75,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Prince Joshua S. · Chief Operating Officer
Table II: Derivative
2 lines| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2026-04-07 | Grant or award : show line 1 in the form Incentive Stock Option (right to buy) | +18,752 | 18,752 | D |
| 2026-04-07 | Grant or award : show line 2 in the form Non-Qualified Stock Option (right to buy) | +56,248 | 56,248 | D |
Loading xslF345X06/edgardoc.xml…